{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T12:36:22Z","timestamp":1788611782532,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lineage plasticity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) and contributes to tumor heterogeneity and therapeutic resistance. Here, we identify KLF5 as a dynamic master regulator of epithelial lineage identity in PDAC, with dichotomous roles in promoting either classical or basal-like transcriptional programs. Through unbiased proteomic and genetic screens, we uncover the AAA+ ATPases RUVBL1 and RUVBL2 as essential coactivators of KLF5 across both lineage states. We demonstrate that ATP hydrolysis by RUVBL1\/2 is required for the stable interaction with an intrinsically disordered region of KLF5, enabling its recruitment to lineage-specific enhancers and driving transcriptional regulation of identity-defining genes. Notably, small-molecule inhibitors of RUVBL1\/2 ATPase activity, which have anti-PDAC activity in vivo, suppress KLF5-dependent transcription. These findings define a previously unrecognized mechanism of ATP hydrolysis-dependent transcriptional coactivation and highlight a potential therapeutic strategy for modulating aberrant lineage programs in cancer.<\/jats:p>","DOI":"10.1038\/s41467-025-66007-0","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T10:01:36Z","timestamp":1763200896000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["KLF5 enables dichotomous lineage programs in pancreatic cancer via the AAA+ ATPase coactivators RUVBL1 and RUVBL2"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-6810","authenticated-orcid":false,"given":"Patrick J.","family":"Cunniff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Sivetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damianos","family":"Skopelitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Klingbeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Toobian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Maia-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3371-1445","authenticated-orcid":false,"given":"Mikala","family":"Egeblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-7180","authenticated-orcid":false,"given":"Christopher R.","family":"Vakoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"66007_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"66007_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","volume":"17","author":"\u00c1 Quintanal-Villalonga","year":"2020","unstructured":"Quintanal-Villalonga, \u00c1 et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat. Rev. Clin. Oncol. 17, 360\u2013371 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"66007_CR3","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1535-6108(04)00112-6","volume":"5","author":"CH Chung","year":"2004","unstructured":"Chung, C. H. et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5, 489\u2013500 (2004).","journal-title":"Cancer Cell"},{"key":"66007_CR4","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869\u201310874 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66007_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"66007_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","journal-title":"Nature"},{"key":"66007_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 25, 152\u2013165 (2014).","journal-title":"Cancer Cell"},{"key":"66007_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05729-w","volume":"9","author":"T Risom","year":"2018","unstructured":"Risom, T. et al. Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer. Nat. Commun. 9, 3815 (2018).","journal-title":"Nat. Commun."},{"key":"66007_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/modpathol.2010.200","volume":"24","author":"S Badve","year":"2011","unstructured":"Badve, S. et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod. Pathol. 24, 157\u2013167 (2011).","journal-title":"Mod. Pathol."},{"key":"66007_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nm.2344","volume":"17","author":"EA Collisson","year":"2011","unstructured":"Collisson, E. A. et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 17, 500\u2013503 (2011).","journal-title":"Nat. Med."},{"key":"66007_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey, P. et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature 531, 47\u201352 (2016).","journal-title":"Nature"},{"key":"66007_CR12","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/ng.3398","volume":"47","author":"RA Moffitt","year":"2015","unstructured":"Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168\u20131178 (2015).","journal-title":"Nat. Genet."},{"key":"66007_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","volume":"52","author":"M Chan-Seng-Yue","year":"2020","unstructured":"Chan-Seng-Yue, M. et al. Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution. Nat. Genet. 52, 231\u2013240 (2020).","journal-title":"Nat. Genet."},{"key":"66007_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06081-9","volume":"9","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y. et al. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat. Commun. 9, 3619 (2018).","journal-title":"Nat. Commun."},{"key":"66007_CR15","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1172\/JCI71545","volume":"124","author":"H Watanabe","year":"2014","unstructured":"Watanabe, H. et al. SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas. J. Clin. Invest. 124, 1636\u20131645 (2014).","journal-title":"J. Clin. Invest."},{"key":"66007_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.celrep.2014.05.036","volume":"8","author":"A Mukhopadhyay","year":"2014","unstructured":"Mukhopadhyay, A. et al. Sox2 cooperates with Lkb1 loss in a mouse model of squamous cell lung cancer. Cell Rep. 8, 40\u201349 (2014).","journal-title":"Cell Rep."},{"key":"66007_CR17","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","volume":"384","author":"MM Awad","year":"2021","unstructured":"Awad, M. M. et al. Acquired resistance to KRASG12C inhibition in cancer. N. Engl. J. Med. 384, 2382\u20132393 (2021).","journal-title":"N. Engl. J. Med."},{"key":"66007_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.athoracsur.2014.02.075","volume":"99","author":"M-S Hsieh","year":"2015","unstructured":"Hsieh, M.-S., Jhuang, J.-Y., Hua, S.-F. & Chou, Y.-H. Histologic evolution from adenocarcinoma to squamous cell carcinoma after gefitinib treatment. Ann. Thorac. Surg. 99, 316\u2013319 (2015).","journal-title":"Ann. Thorac. Surg."},{"key":"66007_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","volume":"1","author":"A Hayashi","year":"2020","unstructured":"Hayashi, A. et al. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Nat. Cancer 1, 59\u201374 (2020).","journal-title":"Nat. Cancer"},{"key":"66007_CR20","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/gutjnl-2018-317706","volume":"68","author":"C Maurer","year":"2019","unstructured":"Maurer, C. et al. Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes. Gut 68, 1034\u20131043 (2019).","journal-title":"Gut"},{"key":"66007_CR21","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1136\/gutjnl-2020-321316","volume":"70","author":"SA Camolotto","year":"2021","unstructured":"Camolotto, S. A. et al. Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4\u03b1 and SIX1\/4. Gut 70, 900\u2013914 (2021).","journal-title":"Gut"},{"key":"66007_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccell.2018.02.003","volume":"33","author":"J Andricovich","year":"2018","unstructured":"Andricovich, J. et al. Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors. Cancer Cell 33, 512\u2013526.e8 (2018).","journal-title":"Cancer Cell"},{"key":"66007_CR23","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.celrep.2018.10.051","volume":"25","author":"TDD Somerville","year":"2018","unstructured":"Somerville, T. D. D. et al. TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma. Cell Rep. 25, 1741\u20131755.e7 (2018).","journal-title":"Cell Rep."},{"key":"66007_CR24","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan, S. et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell 184, 6119\u20136137.e26 (2021).","journal-title":"Cell"},{"key":"66007_CR25","doi-asserted-by":"publisher","first-page":"E12343","DOI":"10.1073\/pnas.1812915116","volume":"115","author":"FH Hamdan","year":"2018","unstructured":"Hamdan, F. H. & Johnsen, S. A. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network. Proc. Natl. Acad. Sci. USA 115, E12343\u2013E12352 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66007_CR26","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/cas.14910","volume":"112","author":"Y Luo","year":"2021","unstructured":"Luo, Y. & Chen, C. The roles and regulation of the KLF5 transcription factor in cancers. Cancer Sci. 112, 2097\u20132117 (2021).","journal-title":"Cancer Sci."},{"key":"66007_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/iub.1233","volume":"65","author":"SM Diakiw","year":"2013","unstructured":"Diakiw, S. M., D\u2019Andrea, R. J. & Brown, A. L. The double life of KLF5: opposing roles in regulation of gene-expression, cellular function, and transformation. IUBMB Life 65, 999\u20131011 (2013).","journal-title":"IUBMB Life"},{"key":"66007_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.CD-17-0532","volume":"8","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Somatic superenhancer duplications and hotspot mutations lead to oncogenic activation of the KLF5 transcription factor. Cancer Discov. 8, 108\u2013125 (2018).","journal-title":"Cancer Discov."},{"key":"66007_CR29","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1053\/j.gastro.2011.06.086","volume":"141","author":"BB McConnell","year":"2011","unstructured":"McConnell, B. B. et al. Kr\u00fcppel-like Factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology 141, 1302\u20131313.e6 (2011).","journal-title":"Gastroenterology"},{"key":"66007_CR30","doi-asserted-by":"publisher","first-page":"100932","DOI":"10.1016\/j.jbc.2021.100932","volume":"297","author":"A Paranjapye","year":"2021","unstructured":"Paranjapye, A., NandyMazumdar, M., Browne, J. A., Leir, S.-H. & Harris, A. Kr\u00fcppel-like factor 5 regulates wound repair and the innate immune response in human airway epithelial cells. J. Biol. Chem. 297, 100932 (2021).","journal-title":"J. Biol. Chem."},{"key":"66007_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jcmgh.2019.11.009","volume":"9","author":"C-K Kim","year":"2020","unstructured":"Kim, C.-K. et al. Kr\u00fcppel-like factor 5 regulates stemness, lineage specification, and regeneration of intestinal epithelial stem cells. Cell. Mol. Gastroenterol. Hepatol. 9, 587\u2013609 (2020).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"66007_CR32","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1016\/j.devcel.2022.06.007","volume":"57","author":"DC Liberti","year":"2022","unstructured":"Liberti, D. C. et al. Klf5 defines alveolar epithelial type 1 cell lineage commitment during lung development and regeneration. Dev. Cell 57, 1742\u20131757.e5 (2022).","journal-title":"Dev. Cell"},{"key":"66007_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ydbio.2014.01.002","volume":"387","author":"MO Nandan","year":"2014","unstructured":"Nandan, M. O. et al. Inducible intestine-specific deletion of Kr\u00fcppel-like factor 5 is characterized by a regenerative response in adult mouse colon. Dev. Biol. 387, 191\u2013202 (2014).","journal-title":"Dev. Biol."},{"key":"66007_CR34","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1053\/j.gastro.2017.12.005","volume":"154","author":"P He","year":"2018","unstructured":"He, P., Yang, J. W., Yang, V. W. & Bialkowska, A. B. Kr\u00fcppel-like factor 5, increased in pancreatic ductal adenocarcinoma, promotes proliferation, acinar-to-ductal metaplasia, pancreatic intraepithelial neoplasia, and tumor growth in mice. Gastroenterology 154, 1494\u20131508.e13 (2018).","journal-title":"Gastroenterology"},{"key":"66007_CR35","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1158\/0008-5472.CAN-08-4402","volume":"69","author":"BB McConnell","year":"2009","unstructured":"McConnell, B. B. et al. Haploinsufficiency of Kr\u00fcppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res. 69, 4125\u20134133 (2009).","journal-title":"Cancer Res."},{"key":"66007_CR36","first-page":"723","volume":"8","author":"MO Nandan","year":"2018","unstructured":"Nandan, M. O., Bialkowska, A. B. & Yang, V. W. KLF5 mediates the hyper-proliferative phenotype of the intestinal epithelium in mice with intestine-specific endogenous K-RasG12D expression. Am. J. Cancer Res. 8, 723\u2013731 (2018).","journal-title":"Am. J. Cancer Res."},{"key":"66007_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/path.5153","volume":"246","author":"R Liu","year":"2018","unstructured":"Liu, R. et al. Kr\u00fcpple-like factor 5 is essential for mammary gland development and tumorigenesis. J. Pathol. 246, 497\u2013507 (2018).","journal-title":"J. Pathol."},{"key":"66007_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s43018-020-00134-z","volume":"2","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Nat. Cancer 2, 49\u201365 (2021).","journal-title":"Nat. Cancer"},{"key":"66007_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/embj.201592404","volume":"35","author":"GR Diaferia","year":"2016","unstructured":"Diaferia, G. R. et al. Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer. EMBO J. 35, 595\u2013617 (2016).","journal-title":"EMBO J."},{"key":"66007_CR40","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.sbi.2020.08.010","volume":"67","author":"MI Dauden","year":"2021","unstructured":"Dauden, M. I., L\u00f3pez-Perrote, A. & Llorca, O. RUVBL1-RUVBL2 AAA-ATPase: a versatile scaffold for multiple complexes and functions. Curr. Opin. Struct. Biol. 67, 78\u201385 (2021).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"66007_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1101\/gr.9.1.27","volume":"9","author":"AF Neuwald","year":"1999","unstructured":"Neuwald, A. F., Aravind, L., Spouge, J. L. & Koonin, E. V. AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 27\u201343 (1999).","journal-title":"Genome Res."},{"key":"66007_CR42","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.cell.2004.12.024","volume":"120","author":"R Zhao","year":"2005","unstructured":"Zhao, R. et al. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the Hsp90 chaperone. Cell 120, 715\u2013727 (2005).","journal-title":"Cell"},{"key":"66007_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.molcel.2004.09.033","volume":"16","author":"ZO J\u00f3nsson","year":"2004","unstructured":"J\u00f3nsson, Z. O., Jha, S., Wohlschlegel, J. A. & Dutta, A. Rvb1p\/Rvb2p recruit Arp5p and assemble a functional Ino80 chromatin remodeling complex. Mol. Cell 16, 465\u2013477 (2004).","journal-title":"Mol. Cell"},{"key":"66007_CR44","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1128\/MCB.01567-12","volume":"33","author":"S Jha","year":"2013","unstructured":"Jha, S., Gupta, A., Dar, A. & Dutta, A. RVBs are required for assembling a functional TIP60 complex. Mol. Cell. Biol. 33, 1164\u20131174 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"66007_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1126\/science.1090701","volume":"303","author":"G Mizuguchi","year":"2004","unstructured":"Mizuguchi, G. et al. ATP-driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science 303, 343\u2013348 (2004).","journal-title":"Science"},{"key":"66007_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33433-3","volume":"13","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. The transcriptional coactivator RUVBL2 regulates Pol II clustering with diverse transcription factors. Nat. Commun. 13, 5703 (2022).","journal-title":"Nat. Commun."},{"key":"66007_CR47","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1136\/gutjnl-2023-331519","volume":"73","author":"M Vogt","year":"2024","unstructured":"Vogt, M. et al. Targeting MYC effector functions in pancreatic cancer by inhibiting the ATPase RUVBL1\/2. Gut 73, 1509\u20131528 (2024).","journal-title":"Gut"},{"key":"66007_CR48","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chembiol.2019.12.005","volume":"27","author":"P Yenerall","year":"2020","unstructured":"Yenerall, P. et al. RUVBL1\/RUVBL2 ATPase activity drives PAQosome maturation, DNA replication and radioresistance in lung cancer. Cell Chem. Biol. 27, 105\u2013121.e14 (2020).","journal-title":"Cell Chem. Biol."},{"key":"66007_CR49","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1021\/acschembio.8b00904","volume":"14","author":"VA Assimon","year":"2019","unstructured":"Assimon, V. A. et al. CB-6644 is a selective inhibitor of the RUVBL1\/2 complex with anticancer activity. ACS Chem. Biol. 14, 236\u2013244 (2019).","journal-title":"ACS Chem. Biol."},{"key":"66007_CR50","doi-asserted-by":"publisher","first-page":"2206584","DOI":"10.1002\/advs.202206584","volume":"10","author":"M Li","year":"2023","unstructured":"Li, M. et al. Epigenetic control of translation checkpoint and tumor progression via RUVBL1-EEF1A1 axis. Adv. Sci. 10, 2206584 (2023).","journal-title":"Adv. Sci."},{"key":"66007_CR51","doi-asserted-by":"publisher","first-page":"101982","DOI":"10.1016\/j.xcrp.2024.101982","volume":"5","author":"C Garc\u00eda-Mart\u00edn","year":"2024","unstructured":"Garc\u00eda-Mart\u00edn, C., L\u00f3pez-Perrote, A., Boskovic, J. & Llorca, O. Mechanism of allosteric inhibition of RUVBL1-RUVBL2 ATPase by the small molecule CB-6644. Cell Rep. Phys. Sci. 5, 101982 (2024).","journal-title":"Cell Rep. Phys. Sci."},{"key":"66007_CR52","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41588-024-01790-y","volume":"56","author":"D Maia-Silva","year":"2024","unstructured":"Maia-Silva, D. et al. Interaction between MED12 and \u0394Np63 activates basal identity in pancreatic ductal adenocarcinoma. Nat. Genet. 56, 1377\u20131385 (2024).","journal-title":"Nat. Genet."},{"key":"66007_CR53","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","volume":"164","author":"CJ David","year":"2016","unstructured":"David, C. J. et al. TGF-\u03b2 tumor suppression through a lethal EMT. Cell 164, 1015\u20131030 (2016).","journal-title":"Cell"},{"key":"66007_CR54","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/1078-0432.CCR-17-2994","volume":"24","author":"KL Aung","year":"2018","unstructured":"Aung, K. L. et al. Genomics-driven precision medicine for advanced pancreatic cancer: early results from the COMPASS trial. Clin. Cancer Res. 24, 1344\u20131354 (2018).","journal-title":"Clin. Cancer Res."},{"key":"66007_CR55","doi-asserted-by":"publisher","first-page":"eadd5327","DOI":"10.1126\/science.add5327","volume":"380","author":"C Burdziak","year":"2023","unstructured":"Burdziak, C. et al. Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesis. Science 380, eadd5327 (2023).","journal-title":"Science"},{"key":"66007_CR56","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","volume":"54","author":"WL Hwang","year":"2022","unstructured":"Hwang, W. L. et al. Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nat. Genet. 54, 1178\u20131191 (2022).","journal-title":"Nat. Genet."},{"key":"66007_CR57","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/nmeth.4435","volume":"14","author":"VA Herzog","year":"2017","unstructured":"Herzog, V. A. et al. Thiol-linked alkylation of RNA to assess expression dynamics. Nat. Methods 14, 1198\u20131204 (2017).","journal-title":"Nat. Methods"},{"key":"66007_CR58","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.aao2793","volume":"360","author":"M Muhar","year":"2018","unstructured":"Muhar, M. et al. SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science 360, 800\u2013805 (2018).","journal-title":"Science"},{"key":"66007_CR59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41589-018-0021-8","volume":"14","author":"B Nabet","year":"2018","unstructured":"Nabet, B. et al. The dTAG system for immediate and target-specific protein degradation. Nat. Chem. Biol. 14, 431\u2013441 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"66007_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-019-0767-4","volume":"19","author":"Q Sun","year":"2019","unstructured":"Sun, Q. et al. Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma. Cancer Cell Int. 19, 49 (2019).","journal-title":"Cancer Cell Int."},{"key":"66007_CR61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576.e16 (2017).","journal-title":"Cell"},{"key":"66007_CR62","doi-asserted-by":"publisher","first-page":"8528","DOI":"10.1128\/MCB.23.23.8528-8541.2003","volume":"23","author":"S Miyamoto","year":"2003","unstructured":"Miyamoto, S. et al. Positive and negative regulation of the cardiovascular transcription factor KLF5 by p300 and the oncogenic regulator SET through interaction and acetylation on the DNA-binding domain. Mol. Cell. Biol. 23, 8528\u20138541 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"66007_CR63","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"66007_CR64","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1152\/physrev.00058.2009","volume":"90","author":"BB McConnell","year":"2010","unstructured":"McConnell, B. B. & Yang, V. W. Mammalian Kr\u00fcppel-like factors in health and diseases. Physiol. Rev. 90, 1337\u20131381 (2010).","journal-title":"Physiol. Rev."},{"key":"66007_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nchembio.2538","volume":"14","author":"CM Olson","year":"2018","unstructured":"Olson, C. M. et al. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nat. Chem. Biol. 14, 163\u2013170 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"66007_CR66","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1158\/1541-7786.MCR-07-0267","volume":"5","author":"J Sabates-Bellver","year":"2007","unstructured":"Sabates-Bellver, J. et al. Transcriptome profile of human colorectal adenomas. Mol. Cancer Res. MCR 5, 1263\u20131275 (2007).","journal-title":"Mol. Cancer Res. MCR"},{"key":"66007_CR67","doi-asserted-by":"publisher","first-page":"108819","DOI":"10.1016\/j.celrep.2021.108819","volume":"34","author":"GA Busslinger","year":"2021","unstructured":"Busslinger, G. A. et al. Human gastrointestinal epithelia of the esophagus, stomach, and duodenum resolved at single-cell resolution. Cell Rep. 34, 108819 (2021).","journal-title":"Cell Rep."},{"key":"66007_CR68","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/jnci\/djj103","volume":"98","author":"V Winnepenninckx","year":"2006","unstructured":"Winnepenninckx, V. et al. Gene expression profiling of primary cutaneous melanoma and clinical outcome. J. Natl. Cancer Inst. 98, 472\u2013482 (2006).","journal-title":"J. Natl. Cancer Inst."},{"key":"66007_CR69","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1158\/0008-5472.CAN-22-1742","volume":"82","author":"KL Pitter","year":"2022","unstructured":"Pitter, K. L. et al. Systematic comparison of pancreatic ductal adenocarcinoma models identifies a conserved highly plastic basal cell state. Cancer Res. 82, 3549\u20133560 (2022).","journal-title":"Cancer Res."},{"key":"66007_CR70","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","volume":"20","author":"MJ Henley","year":"2021","unstructured":"Henley, M. J. & Koehler, A. N. Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules. Nat. Rev. Drug Discov. 20, 669\u2013688 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"66007_CR71","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41594-019-0309-8","volume":"26","author":"N Zaware","year":"2019","unstructured":"Zaware, N. & Zhou, M.-M. Bromodomain biology and drug discovery. Nat. Struct. Mol. Biol. 26, 870\u2013879 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"66007_CR72","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrm3920","volume":"16","author":"PE Wright","year":"2015","unstructured":"Wright, P. E. & Dyson, H. J. Intrinsically disordered proteins in cellular signaling and regulation. Nat. Rev. Mol. Cell Biol. 16, 18\u201329 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"66007_CR73","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/biom10030351","volume":"10","author":"F Gao","year":"2020","unstructured":"Gao, F. et al. Bacterial enhancer binding proteins-AAA+ proteins in transcription activation. Biomolecules 10, 351 (2020).","journal-title":"Biomolecules"},{"key":"66007_CR74","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/bip.22333","volume":"99","author":"N Vidangos","year":"2013","unstructured":"Vidangos, N. et al. Structure, function, and tethering of DNA-binding domains in \u03c354 transcriptional activators. Biopolymers 99, 1082\u20131096 (2013).","journal-title":"Biopolymers"},{"key":"66007_CR75","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.str.2010.08.018","volume":"18","author":"B Chen","year":"2010","unstructured":"Chen, B. et al. Engagement of arginine finger to ATP triggers large conformational changes in NtrC1 AAA+ ATPase for remodeling bacterial RNA polymerase. Structure 18, 1420\u20131430 (2010).","journal-title":"Structure"},{"key":"66007_CR76","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1158\/0008-5472.CAN-23-2081","volume":"84","author":"D Chen","year":"2024","unstructured":"Chen, D. et al. RUVBL1\/2 blockade targets YTHDF1 activity to suppress m6A-dependent oncogenic translation and colorectal tumorigenesis. Cancer Res. 84, 2856\u20132872 (2024).","journal-title":"Cancer Res."},{"key":"66007_CR77","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","volume":"14","author":"J Dilly","year":"2024","unstructured":"Dilly, J. et al. Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer. Cancer Discov. 14, 2135\u20132161 (2024).","journal-title":"Cancer Discov."},{"key":"66007_CR78","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1158\/2159-8290.CD-24-0740","volume":"14","author":"A Singhal","year":"2024","unstructured":"Singhal, A. et al. A classical epithelial state drives acute resistance to KRAS inhibition in pancreatic cancer. Cancer Discov. 14, 2122\u20132134 (2024).","journal-title":"Cancer Discov."},{"key":"66007_CR79","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","volume":"168","author":"JE Bradner","year":"2017","unstructured":"Bradner, J. E., Hnisz, D. & Young, R. A. Transcriptional addiction in cancer. Cell 168, 629\u2013643 (2017).","journal-title":"Cell"},{"key":"66007_CR80","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1182\/blood.2019001576","volume":"135","author":"Y Tarumoto","year":"2020","unstructured":"Tarumoto, Y. et al. Salt-inducible kinase inhibition suppresses acute myeloid leukemia progression in vivo. Blood 135, 56\u201370 (2020).","journal-title":"Blood"},{"key":"66007_CR81","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/B978-0-12-420120-0.00008-6","volume":"539","author":"J Spitzer","year":"2014","unstructured":"Spitzer, J. et al. PAR-CLIP (photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation): a step-by-step protocol to the transcriptome-wide identification of binding sites of RNA-binding proteins. Methods Enzymol. 539, 113\u2013161 (2014).","journal-title":"Methods Enzymol."},{"key":"66007_CR82","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1101\/gad.314815.118","volume":"32","author":"Y-H Huang","year":"2018","unstructured":"Huang, Y.-H. et al. POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev. 32, 915\u2013928 (2018).","journal-title":"Genes Dev."},{"key":"66007_CR83","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nbt.3235","volume":"33","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains. Nat. Biotechnol. 33, 661\u2013667 (2015).","journal-title":"Nat. Biotechnol."},{"key":"66007_CR84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"66007_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"66007_CR86","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"66007_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"66007_CR88","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 4, 1521 (2015).","journal-title":"F1000Res."},{"key":"66007_CR89","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66007_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."},{"key":"66007_CR91","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576\u2013589 (2010).","journal-title":"Mol. Cell"},{"key":"66007_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-2849-7","volume":"20","author":"T Neumann","year":"2019","unstructured":"Neumann, T. et al. Quantification of experimentally induced nucleotide conversions in high-throughput sequencing datasets. BMC Bioinform. 20, 258 (2019).","journal-title":"BMC Bioinform."},{"key":"66007_CR93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"66007_CR94","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ram\u00edrez","year":"2014","unstructured":"Ram\u00edrez, F., D\u00fcndar, F., Diehl, S., Gr\u00fcning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187\u2013W191 (2014).","journal-title":"Nucleic Acids Res."},{"key":"66007_CR95","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"66007_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-45839-z","volume":"9","author":"HM Amemiya","year":"2019","unstructured":"Amemiya, H. M., Kundaje, A. & Boyle, A. P. The ENCODE blacklist: identification of problematic regions of the genome. Sci. Rep. 9, 9354 (2019).","journal-title":"Sci. Rep."},{"key":"66007_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).","journal-title":"Genome Biol."},{"key":"66007_CR98","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 8, 281\u2013291.e9 (2019).","journal-title":"Cell Syst."},{"key":"66007_CR99","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn Res."},{"key":"66007_CR100","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1101\/gr.229102","volume":"12","author":"WJ Kent","year":"2002","unstructured":"Kent, W. J. et al. The human genome browser at UCSC. Genome Res. 12, 996\u20131006 (2002).","journal-title":"Genome Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66007-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66007-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:02:22Z","timestamp":1769778142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66007-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66007"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66007-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original version of this article, several citation callouts were incorrect.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the Results section, the sentence originally reading: \u201cRe-analysis of single-cell RNA-sequencing data from a genetically engineered PDAC mouse model<sub>55<\/sub> further confirmed Klf5 upregulation during disease initiation, and demonstrated that Klf5 expression is sustained throughout disease progression (Figs. 1D, S1F)<sub>46,47<\/sub>\u201d should not include refs. 46 and 47 at the end.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the Discussion section, the sentence originally reading: \u201cKLF5 is known to be induced during pancreatic inflammation and stabilized by mutant KRAS to drive acinar-to-ductal metaplasia<sub>36,40<\/sub>. Additionally, prior work implicates KLF5 in sustaining classical PDAC lineage identity41\" should instead cite refs. 34, 38 and 39.","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the Discussion section, the sentence originally reading: \u201cSeveral studies have demonstrated that pharmacological targeting of RUVBL1\/2 can extend the survival of tumor-bearing mice, although the mechanisms that underlie a tumor-specific dependence on RUVBL1\/2 ATPase activity are unclear<sub>49,51,52,76<\/sub>\u201d should instead cite refs. 49, 50, 51, and 76.","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"These errors have been corrected in the HTML and PDF versions of the article.","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.R.V. has received consulting fees from Flare Therapeutics, Roivant Sciences and C4 Therapeutics; has served on the advisory boards of KSQ Therapeutics, Syros Pharmaceuticals and Treeline Biosciences; has received research funding from Boehringer-Ingelheim and Treeline Biosciences; and owns a stock option from Treeline Biosciences. M.E. owns stock in Agios Pharmaceuticals. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9996"}}